Infusion Nursing Notes by Nufactor provides education, resources and support to promote successful patient therapy within the infusion nursing community.

Anaphylaxis Protocols in Home Infusions: Safety Guidelines for Nurses

11. November 2025 Marianna Herrera (0)
Home infusion nursing brings the unique responsibility of providing high-quality care outside the traditional clinical environment. In the home setting nurses are a "One Man Team", unlike the hospitals that provide rapid response teams at a push of a button. While serious adverse drug reactions (ADRs) are rare, anaphylaxis can occur suddenly and without warning, requiring immediate recognition and decisive action. Nufactor patients are staffed with nurses who must undergo vetting and skills assessment prior to providing care to patients. This is done to ensure they are fully prepared to not only safely and effectively complete the infusion but also recognize any adverse drug reactions and be prepared to intervene accordingly. [More]

Managing Infusion Side Effects - Who to Call and When

31. July 2025 Marianna Herrera IVIG Essentials (0)
Timely recognition and communication of side effects during IVIg or SCIG therapy is essential to patient safety and treatment adherence. Reactions vary by patient and can range from mild to severe. As the nurse, you are often the only clinician physically present during infusions—your assessments and communication are critical in managing the patient’s care. If side effects are not managed appropriately and tolerability becomes an issue, the patient may want to stop therapy, which could impact the management of their condition. The following is a guide to help you determine who to call and when. [More]

HYQVIA® 10% — Learn About Expanded FDA-Approval for Treating PIDD and CIDP

23. May 2025 Marianna Herrera Nursing Support (0)
HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Solution, for subcutaneous administration was first FDA-approved in 2014 for primary immunodeficiency (PIDD) in adults. In 2023, HYQVIA® received expanded FDA-approval in PIDD to include pediatric patients aged 2-16. In 2024 HYQVIA® received FDA-approval for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP). [More]

Mastering IV Access at Home: Best Practices for Safe Infusion Therapy

26. March 2025 Marianna Herrera Infusion Basics, Nursing Support (0)
Home infusion therapy requires a high level of knowledge and proficiency in intravenous (IV) skills, including the insertion, management, and monitoring of peripheral IV lines , as well as expertise in central line accessing and management. Strong competency in both peripheral and central access devices is imperative in ensuring patient safety and optimal outcomes. [More]

Understanding Crohn's Disease: Symptoms, Diagnosis, and Treatment Options

24. December 2024 Marianna Herrera Disease States, Nursing Support (0)
Crohn's disease is a chronic inflammatory bowel disease (IBD) characterized by inflammation of the gastrointestinal (GI) tract. Crohn’s disease can affect any part of the digestive tract. Symptoms can include frequent, recurring diarrhea, rectal bleeding, fever, reduced appetite, unexplained weight loss, fatigue, abdominal pain, abdominal cramping, mouth sores and pain or drainage near or around the anus due to inflammation from a tunnel into the skin (fistula). [More]

Living with Chronic Lymphocytic Leukemia (CLL): Understanding the Journey, Symptoms, and Treatment Options

16. September 2024 Marianna Herrera Disease States (0)
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults in Western countries. CLL is a disease of the white blood cells that typically affects adults over the age of 50 and is rarely seen in children. Most people do not have symptoms when diagnosed with CLL; however, some may present with enlarged lymph nodes. In late-stage diagnosis, patients may report fatigue, fever, night sweats, weight loss, pain in the upper left portion of the abdomen (due to an enlarged spleen) and frequent infections. Blood tests are performed to diagnose CLL. [More]

How to Use the IG Side Effects Card

21. July 2023 Marianna Herrera Infusion Basics, IVIG Essentials, Nursing Support (0)
Prior to an infusion visit, we ask nurses to contact patients 12 -24 hours before and complete our Pre-Infusion Checklist (IVIG Pre-Infusion Checklist / SCIG Pre-Infusion Checklist). Nufactor developed the checklist to help the nurse and patient plan for a successful infusion. The list is a great tool and helps nurses guide their patients using a standardized check-off format. The list provides tips to give to the patient the day prior to, the day of, and the day after an infusion. [More]

Payers

IG & Coagulation Resources
Site of Care Savings

Support

Contact Us
Refer a Patient
Become a Patient

About Us

Mission & Vision
Core Values
Careers

Nufactor

Service Model
Accreditation
IgCP, IgCN, CSP

Nufactor, Inc. is the specialty pharmacy subsidiary of FFF Enterprises.

Nufactor Corporate
Headquarters
44900 Winchester Road
Temecula, CA 92590

(800) 323-6832

Home • Terms • Privacy Statement • • About Us • Careers
©2022 Nufactor